Arrowhead Pharmaceuticals (ARWR) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ARWR Stock Alerts $22.33 -0.28 (-1.24%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Arrowhead Pharmaceuticals Short Interest DataCurrent Short Volume8,870,000 sharesPrevious Short Volume9,200,000 sharesChange Vs. Previous Month-3.59%Dollar Volume Sold Short$253.68 millionShort Interest Ratio / Days to Cover6.2Last Record DateMarch 31, 2024Outstanding Shares123,900,000 sharesPercentage of Shares Shorted7.16%Today's Trading Volume965,833 sharesAverage Trading Volume1,486,377 sharesToday's Volume Vs. Average65% Short Selling Arrowhead Pharmaceuticals ? Sign up to receive the latest short interest report for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARWR Short Interest Over TimeARWR Days to Cover Over TimeARWR Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Arrowhead Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20248,870,000 shares $253.68 million -3.6%N/A6.2 $28.60 3/15/20249,200,000 shares $260.18 million +4.1%N/A5.8 $28.28 2/29/20248,840,000 shares $283.76 million +0.8%N/A5.5 $32.10 2/15/20248,770,000 shares $259.33 million +13.6%N/A5.4 $29.57 1/31/20247,720,000 shares $247.81 million -13.0%N/A5 $32.10 1/15/20248,870,000 shares $323.13 million +18.7%8.8%5.8 $36.43 Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20237,470,000 shares $228.58 million -3.5%7.4%5 $30.60 12/15/20237,740,000 shares $220.98 million +1.6%7.7%6.3 $28.55 11/30/20237,620,000 shares $161.54 million -3.3%7.5%6.5 $21.20 11/15/20237,880,000 shares $212.84 million +9.9%7.8%7.9 $27.01 10/31/20237,170,000 shares $176.31 million +0.6%7.1%7.5 $24.59 10/15/20237,130,000 shares $189.66 million +19.0%7.0%7.5 $26.60 9/30/20235,990,000 shares $160.95 million -1.8%5.9%6.6 $26.87 9/15/20236,100,000 shares $176.41 million -3.6%6.0%6.7 $28.92 8/31/20236,330,000 shares $174.96 million +4.5%6.3%7.1 $27.64 8/15/20236,060,000 shares $177.86 million +8.8%6.0%6.8 $29.35 7/31/20235,570,000 shares $192.28 million +8.0%5.5%6.1 $34.52 7/15/20235,160,000 shares $178.54 million +9.3%5.0%5.2 $34.60 6/30/20234,720,000 shares $168.32 million -5.4%4.6%4.6 $35.66 6/15/20234,990,000 shares $178.34 million +1.0%4.9%5 $35.74 5/31/20234,940,000 shares $169.99 million -5.5%4.8%4.4 $34.41 5/15/20235,230,000 shares $208.62 million +8.1%5.1%4.5 $39.89 4/30/20234,840,000 shares $171.38 million -0.8%4.7%4.2 $35.41 4/15/20234,880,000 shares $148.64 million -1.6%4.7%4.7 $30.46 3/31/20234,960,000 shares $125.98 million -9.8%4.8%4.5 $25.40 3/15/20235,500,000 shares $139.26 million +19.1%5.3%4.9 $25.32 2/28/20234,620,000 shares $149.23 million -2.5%4.4%4.7 $32.30 2/15/20234,740,000 shares $161.40 million +3.5%4.6%4.9 $34.05 1/31/20234,580,000 shares $160.25 million -0.7%4.5%4.4 $34.99 1/15/20234,610,000 shares $169.74 million -2.7%4.5%4.6 $36.82 12/30/20224,740,000 shares $192.25 million +11.8%4.6%5 $40.56 12/15/20224,240,000 shares $133.31 million +7.1%4.2%4.8 $31.44 11/30/20223,960,000 shares $127.51 million +6.2%3.8%4.6 $32.20 11/15/20223,730,000 shares $125.55 million -4.4%3.6%4.5 $33.66 10/31/20223,900,000 shares $135.76 million -1.0%3.8%5 $34.81 10/15/20223,940,000 shares $126.16 million +1.8%3.9%5.1 $32.02 9/30/20223,870,000 shares $127.90 million -9.2%3.8%5.1 $33.05 9/15/20224,260,000 shares $149.65 million +1.9%4.2%5.4 $35.13 8/31/20224,180,000 shares $165.99 million -4.4%4.1%5.2 $39.71 8/15/20224,370,000 shares $211.11 million -9.5%4.3%5.5 $48.31SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ARWR Short Interest - Frequently Asked Questions What is Arrowhead Pharmaceuticals' current short interest? Short interest is the volume of Arrowhead Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 8,870,000 shares of ARWR short. Learn More on Arrowhead Pharmaceuticals' current short interest. What is a good short interest ratio for Arrowhead Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARWR shares currently have a short interest ratio of 6.0. Learn More on Arrowhead Pharmaceuticals's short interest ratio. Which institutional investors are shorting Arrowhead Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arrowhead Pharmaceuticals: Barclays PLC, Wolverine Trading LLC, Citadel Advisors LLC, Capital Fund Management S.A., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Arrowhead Pharmaceuticals' short interest increasing or decreasing? Arrowhead Pharmaceuticals saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 8,870,000 shares, a decline of 3.6% from the previous total of 9,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arrowhead Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arrowhead Pharmaceuticals: HUTCHMED (China) Limited (0.29%), ACADIA Pharmaceuticals Inc. (6.80%), IDEAYA Biosciences, Inc. (14.29%), MoonLake Immunotherapeutics (16.21%), Amicus Therapeutics, Inc. (11.00%), Xenon Pharmaceuticals Inc. (3.66%), MorphoSys AG (1.08%), Indivior PLC (0.13%), Bausch Health Companies Inc. (6.31%), Janux Therapeutics, Inc. (11.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Arrowhead Pharmaceuticals stock? Short selling ARWR is an investing strategy that aims to generate trading profit from Arrowhead Pharmaceuticals as its price is falling. ARWR shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arrowhead Pharmaceuticals? A short squeeze for Arrowhead Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARWR, which in turn drives the price of the stock up even further. How often is Arrowhead Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARWR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: HCM Short Squeeze ACAD Short Squeeze IDYA Short Squeeze MLTX Short Squeeze FOLD Short Squeeze XENE Short Squeeze MOR Short Squeeze INDV Short Squeeze BHC Short Squeeze JANX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARWR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends